Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.
Yoko EdahiroTomonori OchiaiYoshinori HashimotoMichiko IchiiTakeshi OkataniHiromi OmuraKei NakajimaMakoto SasakiJun AndoTomoiku TakakuMichiaki KoikeKoh IzumiyamaJunji HiragaTomofumi YanoKensuke UsukiEiichi OhtsukaKenji YokoyamaTatsuo OyakeNaoki TakahashiTetsuya NishidaTakafumi NakaoYasutaka FukudaTakashi AkasakaAtsuko MugitaniMiki AndoNorio KomatsuPublished in: Hematology (Amsterdam, Netherlands) (2024)
Our data indicate that if aggressive lymphoid neoplasms develop during the course of treatment in patients with MPNs, it is acceptable to prioritize chemotherapy for lymphoma.